Sweden vs World: Access to anti-retroviral drugs, female
Sweden
96.0%
in 2022
World
83.0%
in 2024
Sweden rank
14th
World rank
15th
Access to anti-retroviral drugs, female over time
- Sweden
- World
How they compare
Sweden currently reports 96.0% against 83.0% in World, a difference of 13.0%.
That makes Sweden's figure about 1.2 times World's.
Across all 23 years both countries report, Sweden has been ahead every year.
Sweden ranks 14th and World ranks 15th of 141 countries.
Sweden has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Sweden | World | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 41.9% | 6.5% | 35.4% | Sweden |
| 2010s | 89.5% | 49.3% | 40.2% | Sweden |
| 2020s | 95.7% | 75.7% | 20.0% | Sweden |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Sweden or World?
- Sweden, at 96.0% against 83.0% in World as of 2022.
- What is the difference in access to anti-retroviral drugs, female between Sweden and World?
- 13.0%, with Sweden ahead.
- How many years of comparable data are there for Sweden and World?
- 23 years are reported by both, from 2000 to 2022.
- How do Sweden and World rank globally for access to anti-retroviral drugs, female?
- Sweden ranks 14th and World ranks 15th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.